» Articles » PMID: 22019846

Down Syndrome As a Model of DNA Polymerase Beta Haploinsufficiency and Accelerated Aging

Overview
Journal Mech Ageing Dev
Specialty Geriatrics
Date 2011 Oct 25
PMID 22019846
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Down syndrome is a condition of intellectual disability characterized by accelerated aging. As with other aging syndromes, evidence accumulated over the past several decades points to a DNA repair defect inherent in Down syndrome. This evidence has led us to suggest that Down syndrome results in reduced DNA base excision repair (BER) capacity, and that this contributes to the genomic instability and the aging phenotype of Down syndrome. We propose important roles for microRNA and/or folate metabolism and oxidative stress in the dysregulation of BER in Down syndrome. Further, we suggest these pathways are involved in the leukemogenesis of Down syndrome. We have reviewed the role of BER in the processing of oxidative stress, and the impact of folate depletion on BER capacity. Further, we have reviewed the role that loss of BER, specifically DNA polymerase beta, plays in accelerating the rate of aging. Like that seen in the DNA polymerase beta heterozygous mouse, the aging phenotype of Down syndrome is subtle, unlike the aging phenotypes seen in the classical progeroid syndromes and mouse models of aging. As such, Down syndrome may provide a model for elucidating some of the basic mechanisms of aging.

Citing Articles

Emerging role of cellular senescence in normal lung development and perinatal lung injury.

Dennery P, Yao H Chin Med J Pulm Crit Care Med. 2024; 2(1):10-16.

PMID: 38567372 PMC: 10987039. DOI: 10.1016/j.pccm.2024.01.001.


Polymerases and DNA Repair in Neurons: Implications in Neuronal Survival and Neurodegenerative Diseases.

Li X, Cao G, Liu X, Tang T, Guo C, Liu H Front Cell Neurosci. 2022; 16:852002.

PMID: 35846567 PMC: 9279898. DOI: 10.3389/fncel.2022.852002.


Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.

Martinez de Lagran M, Elizalde-Torrent A, Paredes R, Clotet B, Dierssen M J Cell Mol Med. 2022; 26(15):4210-4215.

PMID: 35762509 PMC: 9344819. DOI: 10.1111/jcmm.17411.


Challenges of proving a causal role of somatic mutations in the aging process.

Franco I, Revechon G, Eriksson M Aging Cell. 2022; 21(5):e13613.

PMID: 35435316 PMC: 9124308. DOI: 10.1111/acel.13613.


Circadian Sleep-Activity Rhythm across Ages in Down Syndrome.

Lovos A, Bottrill K, Sakhon S, Nyhuis C, Egleson E, Luongo A Brain Sci. 2021; 11(11).

PMID: 34827402 PMC: 8615672. DOI: 10.3390/brainsci11111403.